Latest Breaking News On - Elisa chenailler - Page 1 : comparemela.com

Galapagos NV: Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis

OLINGUITO Phase 3 program in adults with axial spondyloarthritis (AxSpA) to include two parallel studies to investigate the efficacy and safety of filgotinib in patients with active radiographic AxSpA

Nordrhein westfalenRegion flamandeUnited kingdomNorthern irelandGreat britainVan gijselMarieke vermeerschDaniele dambrosioXenofon baraliakosElisa chenaillerSandra cauwenberghsEuropean unionJapanese ministry of healthUniversity bochumExchange commissionEuropean medicines agency

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis

Investegate announcements from Galapagos NV, Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis

Nordrhein westfalenUnited kingdomRegion flamandeNorthern irelandGreat britainVan gijselDaniele dambrosioMarieke vermeerschXenofon baraliakosElisa chenaillerSandra cauwenberghsPercentage of participants achieving spondyloarthritis international societyEuropean unionJapanese ministry of healthGilead sciences incUniversity bochum

Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis

Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

United kingdomRegion flamandeNordrhein westfalenNorthern irelandGreat britainElisa chenaillerVan gijselSandra cauwenberghsDaniele dambrosioMarieke vermeerschXenofon baraliakosPercentage of participants achieving spondyloarthritis international societyEuropean unionJapanese ministry of healthEuropean medicines agencyGilead sciences inc

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders meeting

Investegate announcements from Galapagos NV, Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meeting

Region flamandeElisa chenaillerEllen lombaertsSandra cauwenberghsPeter guenterVan gijselMarieke vermeerschLinda higginsDanielo dayInvestegate announcementsInvestegate company announcementsGalapagos nvLobenewswire and globenewswire

Galapagos NV: Galapagos shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders meeting

Mechelen, Belgium; 25 April 2023, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces the approval of all resolutions proposed at its annual shareholders' meeting (AGM)

Region flamandeSandra cauwenberghsMarieke vermeerschPeter guenterElisa chenaillerVan gijselEllen lombaertsLinda higginsDanielo day